--- On Sun, 5/9/10, Klaus Fütterer <[log in to unmask]> wrote:
> Dear Jack,
>
> I believe your venture would enter a mature market, and, if
> you were to offer growing growing crystals in microgravity,
> a market characterised by very high costs and (presumably)
> very low margins.
I wouldn't offer crystal growth, I would offer access to the data from x-ray diffraction of space-grown crystals. Is the data from significantly improved crystals not a valuable commodity?
If the pharmaceutical industry (and other researchers, for that matter) could grow crystals in space, and extract critical data from the x-ray diffraction of these space-grown crystals (in space); AND
if costs could be reduced by 30-50%; AND
if the end-product is the data, not the crystals . . .
do you still think (profit) margins would be nominal?
Is your assessment of "very low margins" based on assumed "very high costs?"
Jack
|